Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-inflammatory agents and renal function.

D Craig Brater1

  • 1Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Seminars in Arthritis and Rheumatism
|January 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The American Society for Clinical Pharmacology and Therapeutics: Programs to support education in clinical pharmacology.

Clinical pharmacology and therapeutics·2017
Same author

Future of the American Society for Clinical Pharmacology and Therapeutics.

Clinical pharmacology and therapeutics·2017
Same author

Sodium and Fluid Excretion With Torsemide in Healthy Subjects is Limited by the Short Duration of Diuretic Action.

Journal of the American Heart Association·2017
Same author

Letter to the editor response.

Sports health·2014
Same author

Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension.

BMC cardiovascular disorders·2012
Same author

Recommendations of the national football league physician society task force on the use of toradol(®) ketorolac in the national football league.

Sports health·2012
Same journal

Autoantibody associations in patients with early diffuse cutaneous systemic sclerosis: the prospective registry of early systemic sclerosis.

Seminars in arthritis and rheumatism·2026
Same journal

Effectiveness and safety of primary thromboprophylaxis in antiphospholipid antibody carriers by serological 2023 ACR/EULAR domains.

Seminars in arthritis and rheumatism·2026
Same journal

Clustering-based stratification of fibromyalgia subtypes: A comparative analysis of medicated and non-medicated cohorts from two academic centers.

Seminars in arthritis and rheumatism·2026
Same journal

Imaging techniques for assessing the hand in systemic sclerosis: a systematic review.

Seminars in arthritis and rheumatism·2026
Same journal

Evaluating unsupervised and rule-based phenotyping methods versus administrative code counts for systemic sclerosis identification.

Seminars in arthritis and rheumatism·2026
Same journal

Associations between MRI features and pain in first metatarsophalangeal joint osteoarthritis.

Seminars in arthritis and rheumatism·2026
See all related articles

Traditional nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase (COX)-2 inhibitors (coxibs) impact kidney function. Patients at risk require careful monitoring for adverse renal events with both drug classes.

Area of Science:

  • Nephrology
  • Pharmacology

Background:

  • Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2, are present in the kidney and involved in prostaglandin synthesis.
  • Prostaglandins play a crucial role in maintaining renal function, especially in susceptible individuals.

Purpose of the Study:

  • To review the effects of traditional nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase (COX)-2 selective inhibitors (coxibs) on renal function.
  • To highlight potential risks and monitoring considerations for patients receiving these medications.

Main Methods:

  • Review of existing studies comparing NSAIDs and coxibs regarding renal function.
  • Analysis of effects on sodium excretion, glomerular filtration rate, blood pressure, and edema.

Main Results:

Related Experiment Videos

  • Both NSAIDs and coxibs can cause transient decreases in sodium excretion.
  • In prostaglandin-dependent kidneys, both drug classes may reduce glomerular filtration rate, potentially leading to hypertension and edema.
  • Inconsistent results exist regarding comparative effects on blood pressure and edema due to varied study designs.

Conclusions:

  • Patients with compromised renal function, heart failure, liver disease, or those on diuretics or ACE inhibitors are at higher risk for adverse renal events.
  • Both nonselective NSAIDs and coxibs warrant cautious monitoring in at-risk populations due to potential renal effects.
  • Further rigorous studies are needed for direct drug comparisons at effective doses.